Allied Market Research
Loading...
0
Upcoming Allied Market Research
2022
Radiopharmaceuticals Market

Radiopharmaceuticals Market by Radioisotop (Technetium-99, Fluorine-18, Iodine-131, Leutetium-177, Yttrium-90, Gallium-68, Gallium-67, Rubidium-82, Iodine-123, Iodine-125, Indium-111, and Others), Source (Cyclotrons, and Nuclear Reactors), and Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A14458
Pages: NA
Jan 2022 | 81 Views
   
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Radiopharmaceuticals Market

Request Now !

Radiopharmaceuticals are pharmaceutical drugs that have radioactivity. Radiopharmaceuticals are used as therapeutic and diagnostic agents. They are medicinal formulations that contain radioisotopes and are majorly used in clinical areas for therapy or diagnosis. Over the last few decades, biology, immunology, and genetics have progressed due to which the development of neurological, oncological, and cardiological therapies have received push.
 In the past two decades, multiple radionuclide-based targeted therapies have emerged as one the most advanced therapies used for inflammatory lesions and cancer treatment. Currently, an array of therapeutic radionuclides, mainly β−emitters, is rising beings used for clinical trials as well as clinics.

Market Scope and Structure Analysis:

Report Metric

Details

  Market size available for years

  2021–2030

  Base year considered

  2020

  Forecast period

  2021–2030

  Forecast units

  Value (USD)

  Segments covered

  Radioisotop, Source, Application, and Region

  Geographies covered

  North America, Europe, Asia-Pacific, and LAMEA

  Companies covered

Major players analyzed include GE Healthcare,  antheus Medical Imaging, Inc., Mallinckrodt, Siemens Healthineers, Advanced Accelerator Application, Bayer AG, Eckert & Ziegler, IBA Radiopharma Solutions, Philips, Jubilant Life Sciences Limited

 

Impact of COVID-19 Pandemic on the Radiopharmaceuticals Market

  • The outbreak of COVID-19 is likely to have a moderate impact on the market in the forecast period. Research and development activities to identify the threat of SARS-CoV-2 virus on the patients suffering are likely to slow the radiopharmaceuticals market growth.
  • COVID-19 has brought about a significant burden on the healthcare industry globally, with disruption in the treatment of non-communicable diseases. Challenges exist in providing effective care.
  • Realizing the disturbing healthcare trends, governments are making efforts to provide excellent quality healthcare to patients globally. Nationwide lockdowns, canceled or postponed elective surgeries, denied wound care services, rise in skin injuries may lead to a decline during the forecast timeline. However, on the flip side, the latter half of the forecast is predicted to show a drastic rise.

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The prevalence of chronic diseases like cardiovascular diseases and cancer are rising rapidly worldwide due to the aging population, rising obesity, and unhealthy food habits. For example, as per the American Heart Association, cardiovascular diseases alone account for nearly 17.3 million deaths every year, which is more deaths caused due to cancer.

Radiopharmaceuticals give an upper hand to radiologists in comparison to conventional medications for the treatment of diseases owing to benefits provided due to radiopharmaceuticals like targeted therapy. These advantages are expected to boost the radiopharmaceuticals market. According to the Healthcare Quality Improvement Partnership (HQIP) report, about 9,200 new cases of neck and head cancers are diagnosed in Wales and England every year. Increasing situations are witnessed to boost the market growth of radiopharmaceuticals, worldwide.

 Radiopharmaceuticals play an important role in the diagnosis of several diseases by resulting in a better understanding of disease staging. Radiopharmaceuticals are linked with chemical compounds that permit specified physiological processes. Benefits of radiopharmaceuticals such as non-invasive external monitoring and efficacy have increased global radioisotope production for use in therapeutic nuclear medicines and molecular imaging. These benefits are anticipated to fuel the growth of the market for radiopharmaceuticals.

As per the World Nuclear Association, radioisotopes are also useful in medicine over 10,000 hospitals globally and 90% of procedures involve diagnosis of cancer, infectious diseases, neurological disorders. The diagnostic use of radiopharmaceuticals is complex and more varied and on the flip side, it contributes to significant growth in the nuclear imaging industry.

North America region will dominate the radiopharmaceuticals market due to the strong presence of a vast patient population who are suffering from coronary disorders, strokes, cancer and the rise in research and development for lesser side effects and effective therapies. Asia-Pacific is predicted to expand the market at a significant growth rate in the forecast timeline because of an increasing number of geriatric populations who require invasive therapies for treating cases related to cardiovascular disorders.

Key Segments Covered:

Segments

Sub-segments

  Radioisotope

  • Technetium-99
  • Fluorine-18
  • Iodine-131
  • Leutetium-177
  • Yttrium-90
  • Gallium-68
  • Gallium-67
  • Rubidium-82
  • Iodine-123
  • Iodine-125
  • Indium-111
  • Others

 Source

 

  • Cyclotrons
  • Nuclear Reactors

   Application

  • Oncology
  • Cardiology
  • Gastroenterology
  • Neuroendocrinology
  • Neurology
  • Nephrology
  • Others

  Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of the Report:

  • This study presents the analytical depiction of the global radiopharmaceuticals market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global radiopharmaceuticals market share.
  • The current market is quantitatively analyzed from 2021 to 2030 to highlight the global radiopharmaceuticals market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global radiopharmaceuticals market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions Answered in the Radiopharmaceuticals Market Research Report:

  • What are the leading market players active in the radiopharmaceuticals market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Radiopharmaceuticals Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers